Increasing prevalence of chronic diseases and autoimmune disorders, steadily rising number of fc fusion protein drug approvals, and rapid advancements in fc fusion protein are some key factors expected to fuel global market growth.
Increasing prevalence of chronic diseases and autoimmune disorders, steadily rising number of fc fusion protein drug approvals, and rapid advancements in fc fusion protein are some key factors expected to fuel global market growth
According to Emergen Research, the global Fc fusion protein market size was USD 26.97 billion in 2020 and is expected to reach USD 59.48 billion in 2028 and register a steady revenue CAGR of 10.5% during the forecast period, 2021-2028.
Market Dynamics:
Fc fusion proteins, also known as Fc tag proteins, Fc chimeric fusion proteins, or Ig-based chimeric proteins are bioengineered polypeptides that join the Fc domain of an antibody with another biologically active protein peptide or domain. These Fc fusion proteins have become one of the curial substances for in vivo and in vitro research. Factors such as increasing applications of fusion proteins for treating various diseases, growing geriatric population, rapidly growing healthcare sector, and rising healthcare expenditure are expected to fuel global market revenue growth during the forecast period. In addition, increasing demand for Fc fusion proteins for drug discovery, vaccine production, in vivo and in vitro research activities, and high demand for biosimilars in clinical trials are other factors expected to drive global market growth going ahead.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/816
However, side effects of recombinant eloctate with Fc fusion protein, implementation of stringent government regulations regarding clinical trials and marketing Fc fusion protein drugs, and lack of funds for research activities especially in developing countries are key factors that can hamper overall market growth during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Diabetes Segment to Account for Largest Revenue Share:
The diabetes segment is expected to account for largest revenue share during the forecast period. This can be attributed to factors such as rising prevalence of diabetes across the globe, growing geriatric population, high usage of Fc fusion protein in diabetic medication and treatment, and increasing investments for developing advanced diabetes therapeutics.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/816
Hospitals Segment Register Rapid Revenue CAGR:
The hospitals segment revenue is expected to register rapid revenue CAGR between 2021 and 2028. Factors such as large patient pool, rising number of patient admission in hospitals, availability of advanced treatment facilities and increasing demand for Fc fusion protein for treating autoimmune diseases, hemophilia, cancer, eye diseases are expected to drive revenue growth of the segment.
North America To Lead In Terms of Revenue Share:
North America is expected to dominate other regional markets in terms of revenue share over the forecast period owing to factors such as increasing geriatric population, rising prevalence of chronic and autoimmune diseases, and availability of advanced healthcare and research facilities and systems. North America market revenue growth is also driven by factors such as increasing investments in research and development activities, growing demand for Fc fusion protein-based drugs, rising number of Fc fusion protein-based drug approvals, and presence of leading pharmaceutical and biotechnology companies.
Major Companies in the Market Include:
- Sanofi S.A.
- Bristol-Myers Squibb Company
- Amgen Inc.
- Pfizer Inc.
- Swedish Orphan Biovitrum AB
- Eli Lilly and Company
- Astellas Pharma Inc.
- Bayer AG
- Regeneron Pharmaceuticals, Inc.
- 3SBio Inc.
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/fc-fusion-protein-market
For the purpose of this report, Emergen Research has segmented the global Fc fusion protein on the basis of type, therapeutic area, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2018–2028)
- Biosimilar Drugs
- Brands Drugs
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
- Eye Diseases
- Hemophilia
- Autoimmune Disease
- Diabetes
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- In Vitro
- Immunohistochemistry
- Flow Cytometry
- Binding Assays
- Microarray Technologies
- In Vivo
- Bio-therapeutic Drugs
End Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Ophthalmic Hospitals
- Oculoplastic Clinics
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Latest Reports Published by Emergen Research:
Mobile App Development Platforms Market By Deployment (Cloud, On-premises), By Organization Size (Large Enterprises, Small & Medium-sized Businesses), By Operating System (Android, iOS, Others), By End-Use (Healthcare, BFSI, Retail, and Others), and By Region Forecast to 2028.
Metaverse in Media and Entertainment Market, By Technology (Blockchain, AI, AR, VR, XR, MR, IoT), By Product (Cryptocurrency, NFTs, Digital Assets, Others), By End-Use (Film Production Companies, Music Labels, OTT Platforms, Television Broadcasters, Artists, Others), and By Region Forecast to 2030.
Cloud Database Security Market Size, Share, Trends, By Type (Public Cloud, Private Cloud, Hybrid Cloud), By Application (Cloud Activity Monitoring, User Authentication, Others), By Industry Vertical, and By Region Forecast to 2028.
Metaverse in Education Market by Technology (AR, VR, XR, MR), By Device (VR Headset, AR Glasses), By Application (Learning, Skill Development, Educational Apps, Self-Regulation Skills, Cultural Understanding, Others), and By Region Forecast to 2030.
Neurological Game Technology Market, By Component (Hardware, Software), By Technology (Brain-Computer Interface, Augmented Reality (AR) Technology, Virtual Reality (VR) Technology, Haptic Technology), By End-Use and By Region Forecast to 2030.
Hadoop Big Data Analytics Market, By Component (Solution, Services), By Deployment (On-premises, Cloud), By Application (Customer Analytics, Risk and Fraud Analytics, Security Intelligence, Internet of Things (IoT), Supply Chain Analytics, Others), By End-Use, and By Region Forecast to 2028.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press release@ https://www.emergenresearch.com/press-release/global-fc-fusion-protein-market